These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1649765)

  • 1. Clearance of S-(3-amino-2-hydroxypropyl) phosphorothioate (WR-77913) in rats.
    Lam TT; Liu D; Brody MA; Chu R; Tso MO
    Exp Eye Res; 1991 Jun; 52(6):661-7. PubMed ID: 1649765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic profile of amifostine.
    Shaw LM; Bonner H; Lieberman R
    Semin Oncol; 1996 Aug; 23(4 Suppl 8):18-22. PubMed ID: 8783662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro metabolism of the phosphorothioate radioprotectors WR-2721 and WR-3689.
    Livesey JC; Rasey JS; Vertrees S; Freeman LM; Magee S; Nelson NJ; Chin L; Grunbaum Z; Krohn KA
    Pharmacol Ther; 1988; 39(1-3):215-7. PubMed ID: 2849127
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of lens opacification in x-irradiated rats treated with WR-77913.
    Osgood TB; Menard TW; Clark JI; Krohn KA
    Invest Ophthalmol Vis Sci; 1986 Dec; 27(12):1780-4. PubMed ID: 3025129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase separation inhibitors and lens transparency.
    Clark JI; Livesey JC; Steele JE
    Optom Vis Sci; 1993 Nov; 70(11):873-9. PubMed ID: 8302522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of phase separation by reagents that prevent X-irradiation cataract in vivo.
    Clark JI; Osgood TB; Trask SJ
    Exp Eye Res; 1987 Dec; 45(6):961-7. PubMed ID: 2828097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delay or inhibition of rat lens opacification using pantethine and WR-77913.
    Clark JI; Livesey JC; Steele JE
    Exp Eye Res; 1996 Jan; 62(1):75-84. PubMed ID: 8674515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of the cytoprotective agent WR-2721 (Amifostine, Ethyol) and its metabolites in human blood using monobromobimane fluorescent labeling and high-performance liquid chromatography.
    Souid AK; Newton GL; Dubowy RL; Fahey RC; Bernstein ML
    Cancer Chemother Pharmacol; 1998; 42(5):400-6. PubMed ID: 9771955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of radiation cataractogenesis by WR-77913.
    Livesey JC; Wiens LW; Von Seggern DJ; Barlow WE; Arnold AM
    Radiat Res; 1995 Jan; 141(1):99-104. PubMed ID: 7997522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioprotection against cataract formation by WR-77913 in gamma-irradiated rats.
    Menard TW; Osgood TB; Clark JI; Spence AM; Steele JE; Krohn KA; Livesey JC
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1483-6. PubMed ID: 3019964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a method for measuring the radioprotective metabolite WR-1065 in plasma using chemical derivatization combined with UHPLC-MS/MS.
    Simon ES; Reyna D; Lister RJ; Harteg C; Lipka E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Mar; 1080():82-89. PubMed ID: 29482122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium hydrogen-S-(3-amino-2-hydroxypropyl) phosphorothioate (WR-77913): toxicity and bone marrow radioprotection.
    Mendiondo OA; Connor AM; Grigsby P
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):553-5. PubMed ID: 6286552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-performance liquid chromatographic assay using electrochemical detection for the combined measurement of amifostine, WR 1065 and the disulfides in plasma.
    Korst AE; Vermorken JB; van der Vijgh WJ
    J Chromatogr B Biomed Sci Appl; 1997 May; 693(1):167-74. PubMed ID: 9200531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the protective effects of three phosphorothioate radioprotectors in the RIF-1 tumor.
    Rasey JS; Krohn KA; Magee S; Nelson N; Chin L
    Radiat Res; 1986 Nov; 108(2):167-75. PubMed ID: 3024202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Light damage in the rat retina: effect of a radioprotective agent (WR-77913) on acute rod outer segment disk disruptions.
    Remé CE; Braschler UF; Roberts J; Dillon J
    Photochem Photobiol; 1991 Jul; 54(1):137-42. PubMed ID: 1658823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of behavioral and radioprotective effects of WR-2721 and WR-3689.
    McDonough JH; Mele PC; Franz CG
    Pharmacol Biochem Behav; 1992 Jun; 42(2):233-43. PubMed ID: 1321450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of S-35 labeled WR-2721 and its metabolites in biological fluids.
    Anderson KW; Krohn KA; Grunbaum Z; Phillips RB; Mahler PA; Menard TW; Spence AM; Rasey JS
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1511-5. PubMed ID: 6090353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo and photophysical studies on photooxidative damage to lens proteins and their protection by radioprotectors.
    Roberts JE; Kinley JS; Young AR; Jenkins G; Atherton SJ; Dillon J
    Photochem Photobiol; 1991 Jan; 53(1):33-8. PubMed ID: 1851303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of amifostine and its metabolites in the plasma and ascites of a cancer patient.
    Korst AE; Gall HE; Vermorken JB; van der Vijgh WJ
    Cancer Chemother Pharmacol; 1996; 39(1-2):162-6. PubMed ID: 8995515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of amifostine and its analogues on sulfur mustard toxicity in vitro and in vivo.
    Bhattacharya R; Rao PV; Pant SC; Kumar P; Tulsawani RK; Pathak U; Kulkarni A; Vijayaraghavan R
    Toxicol Appl Pharmacol; 2001 Oct; 176(1):24-33. PubMed ID: 11578146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.